These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 191532)

  • 61. Macrophage migration inhibition as a correlate of cell-mediated immunity to herpes simplex virus type 2 in mice.
    Mogensen SC
    Immunobiology; 1982; 162(1):28-38. PubMed ID: 6286467
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Functional heterogeneity and T cell-dependent activation of macrophages from murine sarcoma virus (MSV)-induced tumors.
    Holden HT; Varesio L; Taniyama T; Puccetti P
    Adv Exp Med Biol; 1979; 121B():509-20. PubMed ID: 232622
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
    Levy JP; Leclerc JC
    Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
    [No Abstract]   [Full Text] [Related]  

  • 64. Stimulatory effect of immunization on tumor induction by Moloney murine sarcoma virus.
    Murasko DM; Prehn RT
    J Natl Cancer Inst; 1978 Nov; 61(5):1323-7. PubMed ID: 213613
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.
    Tadakuma T; Kühner AL; Rich RR; David JR; Pierce CW
    J Immunol; 1976 Jul; 117(1):323-30. PubMed ID: 6595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mouse bone marrow-cultured macrophage as indicator cells for mouse and human migration inhibitory factor (MIF).
    Lohmann-Matthes ML; Domzig W; Meerpohl HG
    Eur J Immunol; 1977 Aug; 7(8):585-8. PubMed ID: 332509
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Production of migration inhibitory factor and lymphotoxin by non-T cells.
    Bloom BR; Stoner G; Gaffney J; Shevach E; Green I
    Eur J Immunol; 1975 Mar; 5(3):218-20. PubMed ID: 789088
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes.
    Rocklin RE
    J Clin Invest; 1976 Apr; 57(4):1051-8. PubMed ID: 59738
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chemical characterization of macrophage cytotoxicity factor, macrophage migration inhibitory factor, T-helper cell-replacing factor and colony-stimulating factor from culture supernatants of concanavalin A-stimulated murine spleen cells.
    Hübner L; Kniep EM; Laukel H; Sorg C; Fischer H; Gassel WD; Havemann K; Kickhöfen B; Lohmann-Matthes ML; Schimpl A; Wecker E
    Immunobiology; 1980 Jul; 157(2):169-78. PubMed ID: 6997190
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Specific MIF release by rat lymphocytes following incubation with syngeneic anti-tumor "immune" RNA.
    Waldman SR; Pilch YH
    Cell Immunol; 1975 Jul; 18(1):246-50. PubMed ID: 1095213
    [No Abstract]   [Full Text] [Related]  

  • 71. Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.
    Gomard E; Duprez V; Reme T; Colombani MJ; Levy JP
    J Exp Med; 1977 Oct; 146(4):909-22. PubMed ID: 197198
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mouse spleen cell-derived toxoplasma growth inhibitory factor: its separation from macrophage migration inhibitory factor.
    Nagasawa H; Igarashi I; Matsumoto T; Sakurai H; Marbella C; Suzuki N
    Immunobiology; 1980 Dec; 157(4-5):307-19. PubMed ID: 7005083
    [TBL] [Abstract][Full Text] [Related]  

  • 73. H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes.
    Gomard E; Duprez V; Henin Y; Levy JP
    Nature; 1976 Apr; 260(5553):707-9. PubMed ID: 177884
    [No Abstract]   [Full Text] [Related]  

  • 74. Suppression of lymphokine production by macrophages infiltrating murine virus-induced tumors.
    Varesio L; Herberman RB; Gerson JM; Holden HT
    Int J Cancer; 1979 Jul; 24(1):97-102. PubMed ID: 314424
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Suppression of mixed lymphocyte response in mice bearing primary tumors induced by murine sarcoma virus.
    Fernbach BR; Kirchner H; Bonnard GD; Herberman RB
    Transplantation; 1976 May; 21(5):381-6. PubMed ID: 179171
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Suppression of the immune response in tumor-bearing mice. III. Induction of functionally suppressive antigen-driven macrophages.
    Bluestone JA; Lopez C
    Cancer Invest; 1983; 1(1):5-13. PubMed ID: 6199094
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antigenic specificity of cell-mediated antitumor reaction in the MSV system.
    Leclerc JC; Gomard E; Levy JP; Senik A
    Bibl Haematol; 1975 Oct; (43):173-6. PubMed ID: 60997
    [No Abstract]   [Full Text] [Related]  

  • 78. [Induction of macrophage migration inhibition factor-producing cells in vitro].
    Krylov OR; Avdeeva ZhI; Podoplelov II; Medunitsyn NV
    Biull Eksp Biol Med; 1986 Jun; 101(6):715-7. PubMed ID: 3524700
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor.
    Varesio L; Giovarelli M; Landolfo S; Forni G
    Cancer Res; 1979 Dec; 39(12):4983-8. PubMed ID: 159126
    [No Abstract]   [Full Text] [Related]  

  • 80. Functional characteristics of murine macrophages responding to migration inhibitory factors.
    Michels E; Stenzinger W; Sorg C
    Eur J Immunol; 1984 Oct; 14(10):902-5. PubMed ID: 6149130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.